Review and Costing Study into Radiotherapy Services

Date published: 1 February 2022

PwC and its sub-contractor Independent Hospital Pricing Authority (IHPA) engaged PwC and its sub-contractor SyRis Consulting to undertake a review and costing study of Australian radiotherapy services.

The study was commissioned to determine the reliability of radiotherapy cost data due to its role in the development of associated price weights in both admitted and non-admitted settings. The purpose of this review is to assist IHPA and the jurisdictions obtain a better understanding of the cost data that had been submitted to IHPA and to bring to light the costing methodologies employed in services specifically for the pricing of radiotherapy services in 2014/15.

Last updated: 25 August 2022
Is this page useful?

Was this page useful?

Help us improve your IHACPA experience.

Help us improve the IHACPA website

We'd like to know more about your visit today.

 

Was this page useful?

hidden

Describe your experience

hidden_1

Describe your experience

hidden_11

hidden_2

What sector do you represent?

hidden_3